NCT00975819 2026-01-06
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Boston Children's Hospital
Phase 2 Completed
Clinical Trials
3 trialsNCT05050149 2025-01-17
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Palvella Therapeutics, Inc.
Phase 2 Completed
NCT00010452 2015-03-25
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
FDA Office of Orphan Products Development
Phase 2/3 Completed